Elnora AI
Elnora AI uses artificial intelligence to speed antiviral drug discovery by identifying host-cell targets and validating candidates in the wet lab. The company combines machine learning models and AI-driven data analysis with experimental wet-lab testing to translate computational hits into validated antiviral drug candidates. Elnora AI operates as a biotech drug discovery company that partners with research institutions and biomedicine firms and its platform incorporates ML/AI workflows alongside laboratory validation. The technology aims to reduce time and cost to preclinical milestones and to improve robustness against viral mutation. Its focus is antiviral therapeutics targeting host pathways rather than viruses directly.
Elnora AI
Elnora AI uses artificial intelligence to speed antiviral drug discovery by identifying host-cell targets and validating candidates in the wet lab. The company combines machine learning models and AI-driven data analysis with experimental wet-lab testing to translate computational hits into validated antiviral drug candidates. Elnora AI operates as a biotech drug discovery company that partners with research institutions and biomedicine firms and its platform incorporates ML/AI workflows alongside laboratory validation. The technology aims to reduce time and cost to preclinical milestones and to improve robustness against viral mutation. Its focus is antiviral therapeutics targeting host pathways rather than viruses directly.
TL;DR
What they do: AI platform that generates, optimizes, and validates biomedical lab protocols and accelerates antiviral drug discovery by targeting host-cell pathways
Founding / HQ: Founded 2023; headquartered in Tallinn, Estonia
Team size (reported): Approximately 5 employees
Funding signal: One disclosed funding round (convertible note); investor listed: Plug & Play
Customer focus: Enterprise-only (MSA/order-form based) with enterprise security controls
Company Overview
Problem Domain
Biomedical R&D: antiviral therapeutics discovery and lab protocol automation/optimization
Founded
2023
Industry
Biotechnology
Tech Stack
Funding Track Record
One disclosed funding round listed as a convertible note; specific dates and amounts obfuscated in available profiles.
Investor Signal
“Plug & Play (listed as disclosed investor for the convertible note round)”